Torrent Pharmaceuticals Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: TORNTPHARM BSE: 500420

₹4800.00

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #3 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited (this stock)	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹176,547 Cr

EV / EBITDA

38.7x

EV / Sales

14.41x

Market cap / Sales

13.26x

Earnings yield

1.28%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 4,137 Cr, up 58.4% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 492 Cr, down 10.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	4,158	663	492	₹12.9400
March 31, 2026	2,735	592	467	₹13.8000
Dec. 31, 2025	2,599	757	577	₹17.0400
Sept. 30, 2025	2,762	806	597	₹17.6400
June 30, 2025	2,616	742	551	₹16.2800
March 31, 2025	2,433	622	474	₹14.0000
Dec. 31, 2024	2,377	651	485	₹
Sept. 30, 2024	2,434	670	460	₹13.6000
June 30, 2024	2,438	667	469	₹13.8600
March 31, 2024	2,143	530	410	₹12.1200
Dec. 31, 2023	2,123	430	297	₹8.7800
Sept. 30, 2023	2,146	482	327	₹9.6500
June 30, 2023	2,121	475	323	₹9.5500

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Total income (before exceptional items)	4,137	2,793	2,591	2,735	2,611	2,448	2,427	2,459	2,219	2,112	2,161	2,132	1,946
Operating revenue	4,158	2,735	2,599	2,762	2,616	2,433	2,434	2,438	2,143	2,123	2,146	2,121	1,920
Other income	-21	58	-8	-27	-5	15	-7	21	76	-11	15	11	26
Operating expenses	2,585	1,732	1,599	1,690	1,637	1,565	1,513	1,539	1,427	1,422	1,410	1,384	1,342
Operating profit	1,573	1,003	1,000	1,072	979	868	921	899	716	701	736	737	578
Operating profit margin	37.8%	36.7%	38.5%	38.8%	37.4%	35.7%	37.8%	36.9%	33.4%	33.0%	34.3%	34.7%	30.1%
Depreciation	575	197	191	189	187	190	190	189	195	191	192	183	182
Interest	293	225	34	37	45	47	54	64	67	69	77	90	94
Exceptional items, gain / (loss)	-21	-47	-10	-13	—	-24	—	—	—	—	—	—	—
Profit before tax	663	592	757	806	742	622	670	667	530	430	482	475	328
Tax	171	125	180	209	191	148	210	198	120	133	155	152	109
Net profit	492	467	577	597	551	474	460	469	410	297	327	323	219
EPS	12.94	13.80	17.04	17.64	16.28	14.00	13.60	13.86	12.12	8.78	9.65	9.55	6.46
Net profit (TTM)	2,133	2,192	2,199	2,082	1,954	1,813	1,636	1,503	1,357	1,166	1,098	1,043	1,047
EPS (TTM)	61.42	64.76	64.96	61.52	57.74	53.58	48.36	44.41	40.10	34.44	32.44	30.81	40.61

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	10,712	2,897	2,192
March 31, 2025	9,682	2,610	1,888
March 31, 2024	8,533	1,917	1,357
March 31, 2023	7,695	1,577	1,052

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	11.3%	10.3%	10,730^†	—	8,624^†	7,776^†	6,946^†	6,569^†	6,405^†	6,144^†	4,580^†	4,886^†
Operating revenue	11.7%	10.7%	10,712	9,682	8,533	7,695	6,744^†	6,451^†	6,168^†	5,762^†	4,248^†	4,587^†
Other income	—	—	18^†	—	91^†	81^†	202^†	118^†	237^†	382^†	332^†	299^†
Operating expenses	—	—	6,658^†	—	5,643^†	5,190^†	4,639^†	4,254^†	4,251^†	4,149^†	—	3,315^†
Operating profit	17.4%	13.0%	4,054^†	—	2,890^†	2,505^†	2,105^†	2,197^†	1,917^†	1,613^†	—	1,272^†
Operating profit margin	—	—	37.8%^†	—	33.9%^†	32.6%^†	31.2%^†	34.1%^†	31.1%^†	28.0%^†	—	27.7%^†
Depreciation	—	—	764^†	—	761^†	643^†	602^†	610^†	607^†	579^†	—	269^†
Interest	—	—	341^†	—	303^†	298^†	239^†	339^†	430^†	481^†	294^†	202^†
Exceptional items, gain / (loss)	—	—	-70^†	—	0^†	0^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	22.5%	16.2%	2,897	2,610	1,917	1,577	1,466^†	1,366^†	1,117^†	935^†	562^†	955^†
Tax	—	—	705^†	—	560^†	541^†	475^†	228^†	178^†	190^†	80^†	101^†
Net profit	27.7%	14.0%	2,192	1,888	1,357	1,052	991^†	1,138^†	939^†	745^†	482^†	854^†
EPS	16.8%	-0.7%	64.76^†	—	40.10^†	40.61^†	58.59^†	67.24^†	55.46^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	37.8%^†	—	33.9%^†	32.6%^†	31.2%^†	34.1%^†	31.1%^†	28.0%^†	—	27.7%^†
EBIT margin	30.2%^†	—	26.0%^†	24.4%^†	25.3%^†	26.4%^†	25.1%^†	24.6%^†	20.2%^†	25.2%^†
PBT margin	27.0%	27.0%	22.5%	20.5%	21.7%^†	21.2%^†	18.1%^†	16.2%^†	13.2%^†	20.8%^†
Net margin	20.5%	19.5%	15.9%	13.7%	14.7%^†	17.6%^†	15.2%^†	12.9%^†	11.3%^†	18.6%^†
Interest coverage	9.50x^†	—	7.33x^†	6.29x^†	7.13x^†	5.03x^†	3.60x^†	2.94x^†	2.91x^†	5.73x^†
Dividend payout	54.0%^†	—	74.8%^†	34.5%^†	68.3%^†	29.7%^†	37.9%^†	—	—	—
Earnings retention	46.0%^†	—	25.2%^†	65.5%^†	31.7%^†	70.3%^†	62.1%^†	—	—	—
Current ratio	1.07x	1.46x	—	—	—	—	—	—	—	—
Quick ratio	0.73x	0.94x	—	—	—	—	—	—	—	—
Debt to equity	1.68x	0.34x	—	—	—	—	—	—	—	—
Return on equity	25.9%	24.9%	—	—	—	—	—	—	—	—
Return on assets	8.5%	14.7%	—	—	—	—	—	—	—	—
Return on capital employed	15.3%^†	—	—	—	—	—	—	—	—	—
Asset turnover	0.41x	0.75x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	2,731	-12,991	10,226	510	2,221
March 31, 2025	2,574	-470	-2,104	446	2,128
March 31, 2024	2,893	-296	-2,577	344	2,549
March 31, 2023	2,266	-2,327	81	571	1,695
March 31, 2022	2,140	-160	-1,977	108	2,032

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	25,814	8,452	8,283	2,702	11,462	4,891	4,590	71	3,336	1,526
March 31, 2025	12,842	7,592	7,423	1,526	1,021	4,349	2,980	105	3,132	1,561
March 31, 2024	—	—	—	—	—	—	—	—	—	—
March 31, 2023	—	—	—	—	—	—	—	—	—	—
March 31, 2022	—	—	—	—	—	—	—	—	—	—

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.